Biology Reference
In-Depth Information
DNA repair in neuronal apoptosis. Stroke 1999;
30
(2):441
8.
58. Dzagnidze A, Katsarava Z, Makhalova J, et al. Repair capacity for
platinum-DNA adducts determines the severity of cisplatin-
induced peripheral neuropathy. J Neurosci 2007;
e
discussion 9.
40. Sakurai M, Nagata T, Abe K, Horinouchi T, Itoyama Y,
Tabayashi K. Oxidative damage and reduction of redox factor-1
expression after transient spinal cord ischemia in rabbits. J Vasc
Surg 2003;
7.
59. Fischer SJ, McDonald ES, Gross L, Windebank AJ. Alterations in
cell cycle regulation underlie cisplatin induced apoptosis of dorsal
root ganglion neurons in vivo. Neurobiol Dis 2001;
27
(35):9451
e
52.
41. Cleaver JE. Defective repair replication of DNA in xeroderma
pigmentosum. Nature 1968;
37
(2):446
35.
60. Gill JS, Windebank AJ. Cisplatin-induced apoptosis in rat dorsal
root ganglion neurons is associated with attempted entry into the
cell cycle. J Clin Invest 1998;
8
(6):1027
e
e
6.
42. Robbins JH, Kraemer KH, Lutzner MA, Festoff BW, Coon HG.
Xeroderma pigmentosum. An inherited disease with sun sensi-
tivity, multiple cutaneous neoplasms, and abnormal DNA repair.
Ann Intern Med 1974;
218
(5142):652
e
50.
61. McDonald ES, Randon KR, Knight A, Windebank AJ. Cisplatin
preferentially binds to DNA in dorsal root ganglion neurons in
vitro and in vivo: a potential mechanism for neurotoxicity. Neu-
robiol Dis 2005;
101
(12):2842
e
80
48.
43. Robbins JH, Brumback RA, Mendiones M, et al. Neurological
disease in xeroderma pigmentosum. Documentation of a late
onset
(2):221
e
13.
62. Ta LE, Espeset L, Podratz J, Windebank AJ. Neurotoxicity of oxali-
platin and cisplatin for dorsal root ganglion neurons correlateswith
platinum-DNA binding. Neurotoxicology 2006;
18
(2):305
e
type of
the
juvenile onset
form. Brain 1991;
114
61.
44. Balajee AS, May A, Dianov GL, Friedberg EC, Bohr VA. Reduced
RNA polymerase II transcription in intact and permeabilized
Cockayne syndrome group B cells. Proc Natl Acad Sci, USA
1997;
(Pt 3):1335
e
1002.
63. Chvalova K, Brabec V, Kasparkova J. Mechanism of the formation
of DNA-protein cross-links by antitumor cisplatin. Nucleic Acids
Res 2007;
27
(6):992
e
21.
64. Wang D, Lippard SJ. Cellular processing of platinum anticancer
drugs. Nat Rev Drug Discov 2005;
35
(6):1812
e
11.
45. Leadon SA, Cooper PK. Preferential repair of ionizing radiation-
induced damage in the transcribed strand of an active human
gene is defective in Cockayne syndrome. Proc Natl Acad Sci, USA
1993;
94
(9):4306
e
20.
65. David SS, O'Shea VL, Kundu S. Base-excision repair of oxidative
DNA damage. Nature 2007;
4
(4):307
e
50.
66. Gibson NW, Erickson LC, Hickman JA. Effects of the antitumor
agent 8-carbamoyl-3-(2-chloroethyl)imidazo[5,1-d]-1,2,3,5-tetra-
zin-4(3 H)-one on the DNA of mouse L1210 cells. Cancer Res
1984;
447
(7147):941
e
503.
46. Weidenheim KM, Dickson DW, Rapin I. Neuropathology of
Cockayne syndrome: Evidence for impaired development,
premature aging, and neurodegeneration. Mech Ageing Dev
2009;
90
(22):10499
e
71.
67. Kondo N, Takahashi A, Ono K, Ohnishi T. DNA damage induced
by alkylating agents and repair pathways.
44
(5):1767
e
36.
47. Joshi G, Sultana R, Tangpong J, et al. Free radical mediated
oxidative stress and toxic side effects in brain induced by the anti
cancer drug adriamycin: insight into chemobrain. Free Radic Res
2005;
130
(9):619
e
J Nucleic Acids
:543531 [Epub ahead of print].
68. Argyriou AA, Assimakopoulos K, Iconomou G,
Giannakopoulou F, Kalofonos HP. Either called “chemobrain” or
“chemofog,” the long-term chemotherapy-induced cognitive
decline in cancer survivors is real. J Pain Symptom Manage; 2010.
September 9 [Epub ahead of print].
69. Dropcho EJ. Neurotoxicity of cancer chemotherapy. Semin Neurol
2010;
2010;
2010
54.
48. MeijerC, deVries EG,Marmiroli P, Tredici G, FrattolaL, Cavaletti G.
Cisplatin-induced DNA-platination in experimental dorsal root
ganglia neuronopathy. Neurotoxicology 1999;
39
(11):1147
e
7.
49. Podratz JL, Knight AM, Ta LE, et al. Cisplatin induced Mito-
chondrial DNA damage in dorsal root ganglion neurons. Neuro-
biol Dis 2011;
20
(6):883
e
86.
70. Ahles TA, Saykin AJ, Furstenberg CT, et al. Neuropsychologic
impact of standard-dose systemic chemotherapy in long-term
survivors of breast
30
(3):273
e
8.
50. Wardell TM, Ferguson E, Chinnery PF, et al. Changes in the
human mitochondrial genome after treatment of malignant
disease. Mutat Res 2003;
41
(3):661
e
cancer and lymphoma.
J Clin Oncol
93.
71. McDonald BC, Conroy SK, Ahles TA, West JD, Saykin AJ. Gray
matter reduction associated with systemic chemotherapy for
breast cancer: a prospective MRI study. Breast Cancer Res Treat
2010;
2002;
20
(2):485
27.
51. Simpson PB, Russell JT. Role of mitochondrial Ca2
525
(1-2):19
e
e
regulation in
neuronal and glial cell signalling. Brain Res Brain Res Rev
1998;
þ
81.
52. Li Z, Ji G, Neugebauer V. Mitochondrial reactive oxygen species
are activated by mGluR5 through IP3 and activate ERK and PKA
to increase excitability of amygdala neurons and pain behavior. J
Neurosci 2011;
26
(1):72
e
28.
72. Saykin AJ, Ahles TA, McDonald BC. Mechanisms of chemo-
therapy-induced cognitive disorders: neuropsychological, path-
ophysiological, and neuroimaging perspectives. Semin Clin
Neuropsychiatry 2003;
123
(3):819
e
31
27.
53. Witte ME, Geurts JJ, de Vries HE, van der Valk P, van Horssen J.
Mitochondrial dysfunction: a potential link between neuro-
inflammation and neurodegeneration? Mitochondrion 2010;
(3):1114
e
8
16.
73. Silverman DH, Dy CJ, Castellon SA, et al. Altered frontocortical,
cerebellar, and basal ganglia activity in adjuvant-treated breast
cancer survivors 5
(4):201
e
10
10 years after chemotherapy. Breast Cancer Res
8.
54. Kruman II , Wersto RP, Cardozo-Pelaez F, et al. Cell cycle acti-
vation linked to neuronal cell death initiated by DNA damage.
Neuron 2004;
(5):411
e
e
11.
74. Konat GW, Kraszpulski M, James I, Zhang HT, Abraham J.
Cognitive dysfunction induced by chronic administration of
common cancer chemotherapeutics in rats. Metab Brain Dis
2008;
Treat 2007;
103
(3):303
e
61.
55. Shikazono N, Noguchi M, Fujii K, Urushibara A, Yokoya A. The
yield, processing, and biological consequences of clustered DNA
damage induced by ionizing radiation.
41
(4):549
e
33.
75. Liedke PE, Reolon GK, Kilpp B, Brunetto AL, Roesler R,
Schwartsmann G. Systemic administration of doxorubicin
impairs aversively motivated memory in rats. Pharmacol Biochem
Behav 2009;
23
(3):325
e
J Radiat Res (Tokyo)
36.
56. Olive PL. The role of DNA single- and double-strand breaks in
cell killing by ionizing radiation. Radiat Res 1998;
2009;
50
(1):27
e
150
(Suppl 5):
43.
76. Macleod JE, DeLeo JA, Hickey WF, Ahles TA, Saykin AJ,
Bucci DJ. Cancer chemotherapy impairs contextual but not cue-
specific fear memory. Behav Brain Res 2007;
94
(2):239
e
51.
57. Monje ML, Mizumatsu S, Fike JR, Palmer TD. Irradiation induces
neural precursor-cell dysfunction. Nat Med 2002;
S42
e
8
(9):955
e
62.
181
(1):168
e
72.
